Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

NCT00366652 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression
Depressive Disorder
Depressive Disorder, Major

Interventions

DRUG: desvenlafaxine SR
DRUG: desipramine
DRUG: duloxetine

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer